- 米国企業
- ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc.NDRA
| 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 |
---|
Net loss | -5,376,962 | -9,796,261 | -13,305,964 | -11,725,501 | 11 | 13 |
---|
Depreciation and amortization | 61,481 | 68,316 | 80,577 | 99,342 | 116,238 | 96,661 |
---|
Fixed assets write off | - | - | - | - | 9,874 | 1,391 |
---|
Stock compensation expense including common stock issued for RSUs | - | - | - | - | 1 | 1 |
---|
Amortization of right of use assets | - | - | - | - | 108,177 | 137,597 |
---|
Gain on extinguishment of debt | - | - | - | - | 308,600 | - |
---|
Decrease in prepaid expenses | 67,497 | 77,928 | -28,675 | 274,051 | 957,203 | -355,128 |
---|
Increase in inventory | 151,574 | 155,305 | 53,998 | 476,178 | 694,958 | 1 |
---|
Increase in accounts payable and accrued liabilities | 528,294 | 126,368 | 760,143 | -834,990 | 491,104 | 111,575 |
---|
Decrease in lease liability | - | - | - | - | - | -132,330 |
---|
Net cash used in operating activities | -3,300,914 | -7,702,481 | -8,588,851 | -10,746,595 | -11,122,384 | -12,769,371 |
---|
Purchases of fixed assets | - | 100,000 | 43,595 | 75,333 | 45,000 | 202,577 |
---|
Net cash used in investing activities | -7,862 | -100,000 | -43,595 | -75,333 | -45,000 | -202,577 |
---|
Proceeds from warrant exercise | - | - | - | 5 | 3 | - |
---|
Proceeds from issuance of common stock | 9 | 8 | 125,000 | 7 | 11 | 8 |
---|
Net cash provided by financing activities | 9 | 9 | 8 | 12 | 13 | 8 |
---|
Net increase (decrease) in cash | - | - | - | - | 2 | -4,572,436 |
---|
Interest paid | - | 40,085 | - | 1,920 | 57,655 | 59,113 |
---|
Income tax paid | - | - | - | - | - | - |
---|
Deemed dividend | - | - | 4 | 395,551 | 121,071 | - |
---|
Conversion of Series A Convertible Preferred Stock | - | - | - | - | -7 | - |
---|
Stock dividend payable | - | - | - | - | -3,067 | 7,790 |
---|
Right of use asset | - | - | 34,434 | 65,907 | 643,413 | 505,816 |
---|
Lease liability | - | - | - | - | 650,477 | 518,147 |
---|